Gefitinib Avansor

Gefitinib Avansor is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Avansor is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic mutations. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC in patients who test positive for EGFR mutations.

Common effects of Gefitinib Avansor may include skin rash, diarrhea, and nausea. Some patients may also experience fatigue or loss of appetite. These effects can vary in severity and may not affect everyone who takes the medication.

Gefitinib Avansor should be handled with care and stored as directed. It is important to follow the healthcare provider's instructions regarding administration and to report any severe or persistent side effects. Patients with a history of certain medical conditions should discuss their health status with their healthcare provider before starting this medication.

Gefitinib Avansor may interact with other medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, certain foods and supplements may also interact with Gefitinib Avansor.